Granisetron and carvedilol can protect experimental rats againstadjuvant-induced arthritis.
Ahmed YM, Messiha BA, Abo-Saif AA.
Immunopharmacol Immunotoxicol · journal article · DOI 10.1080/08923973.2017.1286502 PUBLIKATIONSREGISTRET
Gå till forskningen.
Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.
Publikationer som ChEBI hänvisar till för granisetron. Visa hela publikationsregistret
En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.
Publikationer i urvalet
30 träffarSimultaneous Determination of Dexamethasone, Ondansetron, Granisetron, Tropisetron, and Azasetron in Infusion Samples by HPLC with DAD Detection.
Chen FC, Wang LH, Guo J, Shi XY, Fang BX.
J Anal Methods Chem · research-article; journal article · DOI 10.1155/2017/6749087Influence of Polymorphisms in the HTR3A and HTR3B Genes on Experimental Pain and the Effect of the 5-HT3 Antagonist Granisetron.
Louca Jounger S, Christidis N, Hedenberg-Magnusson B, List T, Svensson P, Schalling M, Ernberg M.
PLoS One · research-article; randomized controlled trial; journal article · DOI 10.1371/journal.pone.0168703Polymorphisms in CYP1A1 and CYP3A5 Genes Contribute to the Variability in Granisetron Clearance and Exposure in Pregnant Women with Nausea and Vomiting.
Bustos ML, Zhao Y, Chen H, Caritis SN, Venkataramanan R.
Pharmacotherapy · journal article · DOI 10.1002/phar.1860Granisetron Extended-Release Injection: A Review in Chemotherapy-Induced Nausea and Vomiting.
Deeks ED.
Drugs · review; journal article · DOI 10.1007/s40265-016-0664-2Transdermal granisetron for the prevention of nausea and vomiting following moderately or highly emetogenic chemotherapy in Chinese patients: a randomized, double-blind, phase III study.
Yang LQ, Sun XC, Qin SK, Chen YX, Zhang HL, Cheng Y, Chen ZD, Shi JH, Wu Q, Bai YX, Han BH, Liu W, Ouyang XN, Liu JW, Zhang ZH, Li YQ, Xu JM, Yu SY.
Chin Clin Oncol · clinical trial, phase iii; multicenter study; randomized controlled trial; journal article · DOI 10.21037/cco.2016.12.04Carbon monoxide contributes to the constipating effects of granisetron in rat colon.
Nacci C, Fanelli M, Potenza MA, Leo V, Montagnani M, De Salvia MA.
World J Gastroenterol · research-article; journal article · DOI 10.3748/wjg.v22.i42.9333Granisetron Transdermal System for Treatment of Symptoms of Gastroparesis: A Prescription Registry Study.
Midani D, Parkman HP.
J Neurogastroenterol Motil · research-article; journal article · DOI 10.5056/jnm15203Symptomatic Improvement of Gastroparesis with Granisetron Transdermal System.
Jung HK.
J Neurogastroenterol Motil · editorial · DOI 10.5056/jnm16150Expression of Concern: "Prevention of Nausea and Vomiting After Middle Ear Surgery: Granisetron Versus Ramosetron," "Prevention of Vomiting After Tonsillectomy in Children: Granisetron Versus Ramosetron," and "Granisetron, Droperidol, and Metoclopramide for Preventing Postoperative Nausea and Vomiting After Thyroidectomy" by Dr Yoshitaka Fujii.
Författaruppgift saknas
Laryngoscope · journal article; expression of concern · DOI 10.1002/lary.26260Synthesis and Pharmacological Evaluation of [<sup>11</sup>C]Granisetron and [<sup>18</sup>F]Fluoropalonosetron as PET Probes for 5-HT<sub>3</sub> Receptor Imaging.
Mu L, Müller Herde A, Rüefli PM, Sladojevich F, Milicevic Sephton S, Krämer SD, Thompson AJ, Schibli R, Ametamey SM, Lochner M.
ACS Chem Neurosci · journal article · DOI 10.1021/acschemneuro.6b00192Palonosetron and granisetron in postoperative nausea vomiting: A randomized double-blind prospective study.
Gugale AA, Bhalerao PM.
Anesth Essays Res · research-article; journal article · DOI 10.4103/0259-1162.191121Randomized, double-blind, phase III trial of palonosetron versus granisetron in the triplet regimen for preventing chemotherapy-induced nausea and vomiting after highly emetogenic chemotherapy: TRIPLE study.
Suzuki K, Yamanaka T, Hashimoto H, Shimada Y, Arata K, Matsui R, Goto K, Takiguchi T, Ohyanagi F, Kogure Y, Nogami N, Nakao M, Takeda K, Azuma K, Nagase S, Hayashi T, Fujiwara K, Shimada T, Seki N, Yamamoto N.
Ann Oncol · clinical trial, phase iii; randomized controlled trial; journal article · DOI 10.1093/annonc/mdw220Management of chemotherapy-induced nausea and vomiting in patients receiving multiple-day highly or moderately emetogenic chemotherapy: role of transdermal granisetron.
Coluzzi F, Mattia C.
Future Oncol · review; journal article · DOI 10.2217/fon-2016-0097Control of nausea with palonosetron versus granisetron, both combined with dexamethasone, in patients receiving cisplatin- or anthracycline plus cyclophosphamide-based regimens.
Kubota K, Saito M, Aogi K, Sekine I, Yoshizawa H, Yanagita Y, Sakai H, Inoue K, Kitagawa C, Ogura T.
Support Care Cancer · clinical trial, phase iii; research-article; randomized controlled trial; journal article · DOI 10.1007/s00520-016-3203-5Comparison of ondansetron and granisetron for antiemetic prophylaxis in maxillofacial surgery patients receiving general anesthesia: a prospective, randomised, and double blind study.
Savant K, Khandeparker RV, Berwal V, Khandeparker PV, Jain H.
J Korean Assoc Oral Maxillofac Surg · research-article; journal article · DOI 10.5125/jkaoms.2016.42.2.84APF530 (granisetron injection extended-release) in a three-drug regimen for delayed CINV in highly emetogenic chemotherapy.
Schnadig ID, Agajanian R, Dakhil C, Gabrail NY, Smith RE, Taylor C, Wilks ST, Schwartzberg LS, Cooper W, Mosier MC, Payne JY, Klepper MJ, Vacirca JL.
Future Oncol · clinical trial, phase iii; multicenter study; randomized controlled trial; journal article · DOI 10.2217/fon-2016-0070A CASE OF GRANISETRON ASSOCIATED INTRAOPERATIVE CARDIAC ARREST.
Al Harbi M, Al Rifai D, Al Habeeb H, Wambi F, Geldhof G, Dimitriou V.
Middle East J Anaesthesiol · journal article; case reportsGranisetron versus Granisetron-Dexamethasone for Prevention of Postoperative Nausea and Vomiting in Pediatric Strabismus Surgery: A Randomized Double-Blind Trial.
Sinha R, Shende D, Maitra S, Kumar N, Kumar N, Ray BR, Mohan VK.
Anesthesiol Res Pract · research-article; journal article · DOI 10.1155/2016/4281719Pharmacodynamics of transdermal granisetron in women with nausea and vomiting of pregnancy.
Caritis S, Zhao Y, Chen HJ, Venkataramanan R.
Am J Obstet Gynecol · research support, non-u.s. gov't; journal article · DOI 10.1016/j.ajog.2016.01.163Retraction notice. Ramosetron compared with granisetron for the prevention of vomiting following strabismus surgery in children.
Författaruppgift saknas
Br J Ophthalmol · retraction of publication; retraction notice · DOI 10.1136/bjo.85.6.670retSlow-release granisetron (APF530) versus palonosetron for chemotherapy-induced nausea/vomiting: analysis by American Society of Clinical Oncology emetogenicity criteria.
Raftopoulos H, Boccia R, Cooper W, O'Boyle E, Gralla RJ.
Future Oncol · clinical trial, phase iii; research support, non-u.s. gov't; multicenter study; randomized controlled trial; journal article · DOI 10.2217/fon.15.185Pharmacokinetics, safety, and efficacy of APF530 (extended-release granisetron) in patients receiving moderately or highly emetogenic chemotherapy: results of two Phase II trials.
Gabrail N, Yanagihara R, Spaczyński M, Cooper W, O'Boyle E, Smith C, Boccia R.
Cancer Manag Res · research-article; journal article · DOI 10.2147/cmar.s72626Sustained antiemetic responses with APF530 (sustained-release granisetron) during multiple cycles of emetogenic chemotherapy.
Boccia R, Cooper W, O'Boyle E.
J Community Support Oncol · journal article · DOI 10.12788/jcso.0107Biochronomer™ technology and the development of APF530, a sustained release formulation of granisetron.
Ottoboni T, Gelder MS, O'Boyle E.
J Exp Pharmacol · research-article; journal article · DOI 10.2147/jep.s68880[Anti-emetic effect of granisetron in patients undergoing cranial and craniospinal radiotherapy].
Yamasaki F, Watanabe Y, Nosaka R, Kenjo M, Nakamura K, Takayasu T, Saito T, Tominaga A, Sugiyama K, Kurisu K.
No Shinkei Geka · journal article; english abstractPharmacokinetics and repolarization effects of intravenous and transdermal granisetron.
Mason JW, Selness DS, Moon TE, O'Mahony B, Donachie P, Howell J.
Clin Cancer Res · research support, non-u.s. gov't; clinical trial, phase i; randomized controlled trial; journal article · DOI 10.1158/1078-0432.ccr-11-2785First clinical study of the selective 5-HT3 antagonist, granisetron (BRL 43694), in the acute treatment of migraine headache.
Couturier EG, Hering R, Foster CA, Steiner TJ, Clifford Rose F.
Headache · clinical trial; journal article · DOI 10.1111/j.1526-4610.1991.hed3105296.xThe clinical pharmacology of granisetron (BRL 43694), a novel specific 5-HT3 antagonist.
Upward JW, Arnold BD, Link C, Pierce DM, Allen A, Tasker TC.
Eur J Cancer · controlled clinical trial; clinical trial; journal articleSelective and functional 5-hydroxytryptamine3 receptor antagonism by BRL 43694 (granisetron).
Sanger GJ, Nelson DR.
Eur J Pharmacol · journal article · DOI 10.1016/0014-2999(89)90695-x